A six-week study from the University of Nottingham suggests that pairing fermented kefir with a diverse prebiotic fiber mix may deliver a powerful anti-inflammatory boost. This “synbiotic” combination outperformed omega-3 supplements and fiber alone, leading to the broadest drop in inflammation-related proteins in healthy adults. By feeding beneficial microbes and helping them produce compounds li
A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, those who completed five to six weeks of adaptive “speed of processing” training — along with a few booster sessions — were significantly less likely to develop dementia, including Alzheimer’s disease,
A new clinical trial suggests that changing when you eat could make a meaningful difference for people living with Crohn’s disease. Researchers found that time-restricted feeding, a form of intermittent fasting that limits meals to an 8-hour daily window, reduced disease activity by 40% and cut abdominal discomfort in half over 12 weeks. Participants also lost weight and showed healthier inflammat
Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.
The Trump admin is reframing steep Medicaid cuts to pit states with large urban centers against those with large rural populations.
The Trump administration wants the 2027 ACA marketplace to offer plans with lower premiums — but the tradeoff is high deductibles and risk for those needing care.
Massachusetts’ largest life science employer has put more than 630,000 square feet of office space on the sublease market as part of efforts to consolidate the Japanese company’s U.S. corporate hub at a new Cambridge development scheduled to open later this year.
For months now, all signs have pointed to a looming, steep dropoff in pharmas’ spending on traditional TV advertising. One brand that seems not to have gotten the memo, however, is Johnson & Johnson’s Tremfya.
Chinese prosecutors have brought formal charges against AstraZeneca and its former executives following investigations into alleged illegal patient data collection and importation of drugs.
Following a more than decade-long legal back-and-forth over the generic drug carveout practice known as “skinny” labeling, GSK and Teva have put their dispute to bed, new court documents show.
Gilead is expecting newly launched HIV PrEP Yeztugo to bring in $800 million in 2026 sales, a figure Mizuho Securities analysts described as "probably" conservative.
For all its success across a wide range of cancer types, Merck’s superstar Keytruda has never been able to crack the code for one of the toughest-to-treat indications in oncology—ovarian cancer. But now, 13 years after the FDA initially blessed it for skin cancer, the U.S. regulator has approved Keytruda as a second- or third-line treatment for patients with a certain type of ovarian cancer.
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data a
The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.
A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.
As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.
Depression in older adults may sometimes signal the early stages of Parkinson’s disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains elevated long afterward, unlike in other chronic illnesses. This suggests depression may reflect early brain changes rather than emotional distress alone.
A cooler bedroom might be better for older sleepers than previously thought. Researchers found that keeping nighttime temperatures at 75°F reduced stress responses and helped the heart work more efficiently during sleep. Hot nights usually force the heart to work harder, interfering with recovery. As climate change drives warmer nights, this small adjustment could make a big difference.
Why does the same virus barely faze one person while sending another to the hospital? New research shows the answer lies in a molecular record etched into our immune cells by both our genes and our life experiences. Scientists at the Salk Institute have created a detailed epigenetic map of human immune cells, revealing how inherited traits and past exposures—like infections, vaccines, or even envi
FDA refuses to review Moderna’s influenza vaccine, which could raise concerns about the agency’s posture toward vaccines and drug approvals more generally.